Search Results

You are looking at 61 - 70 of 145 items for :

  • "genetic counseling" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Interpretation of Genetic Testing for Lynch Syndrome in Patients With Putative Familial Colorectal Cancer

Christina Rybak and Michael J. Hall

provide ongoing comprehensive genetic risk information to current and past patients. Although tumor testing and risk evaluation have become integral aspects of medical oncology care, the complete process of cancer genetic counseling, from the construction

Full access

Modification and Implementation of NCCN Guidelines™ on Breast Cancer in the Middle East and North Africa Region

Omalkhair Abulkhair, Nagi Saghir, Lobna Sedky, Ahmed Saadedin, Heba Elzahwary, Neelam Siddiqui, Mervat Al Saleh, Fady Geara, Nuha Birido, Nadia Al-Eissa, Sana Al Sukhun, Huda Abdulkareem, Menar Mohamed Ayoub, Fawaz Deirawan, Salah Fayaz, Alaa Kandil, Sami Khatib, Mufid El-Mistiri, Dorria Salem, El Siah Hassan Sayd, Mohammed Jaloudi, Mohammad Jahanzeb, and William I. Gradishar

). Genetic Counseling for High-Risk Women Recommendations: Setup for infrastructure, genetic counselors, and nurses is encouraged and should be prepared along with laws to protect women and families with positive hereditary factors from discrimination at

Full access

NCCN Guidelines Insights: Survivorship, Version 2.2020

Featured Updates to the NCCN Guidelines

Crystal S. Denlinger, Tara Sanft, Javid J. Moslehi, Linda Overholser, Saro Armenian, K. Scott Baker, Gregory Broderick, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Norah Lynn Henry, Christine Hill-Kayser, Melissa Hudson, Nazanin Khakpour, Divya Koura, Allison L. McDonough, Michelle Melisko, Kathi Mooney, Halle C. F. Moore, Natalie Moryl, Tracey O’Connor, Electra D. Paskett, Chirayu Patel, Lindsay Peterson, William Pirl, M. Alma Rodriguez, Kathryn J. Ruddy, Lillie Shockney, Sophia Smith, Karen L. Syrjala, Amye Tevaarwerk, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass

, with genetic counseling and testing as appropriate, is also recommended (see SURV-3 , page 1018). Conclusions Subsequent primary cancers and cardiovascular disease are 2 leading causes of death in cancer survivors. Risk of the former can be mitigated

Full access

The Genetics of Hereditary Non-Polyposis Colorectal Cancer

Stephen B. Gruber and Wendy Kohlmann

and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): Genetic counseling implications . Cancer Epidemiol Biomarkers Prev 1997 ; 6 : 987 – 991 .

Full access

Keynote Session: Reducing Racial Disparities in Oncology—Recommendations for Implementing Guideline-Adherent Cancer Care

Presented by: Shonta Chambers, Elizabeth Harrington, Lisa A. Lacasse, Robert Winn, and moderated by Alyssa A. Schatz

-related genetic counseling and testing . J Genet Couns 2020 ; 29 : 518 – 529 . 32291871 8. Meghani SH , Byun E , Gallagher RM . Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for

Full access

Management of Patients With Nonmetastatic Prostate Cancer

Presented by: Julio M. Pow-Sang

/or potential risk of cancer in family members. If these criteria are met, germline multigene testing should include at least BRCA1 , BRCA2 , ATM , PALB2 , CHEK2 , MLH1 , MSH2 , MSH6 , and PMS2 . Posttest genetic counseling is strongly recommended if

Full access

Hereditary/Familial Ovarian Cancer: Testing Principles and Risk Management

Presented by: Leigha Senter

long time, professional organizations, including NCCN, have recommended that all patients diagnosed with ovarian cancer be offered genetic counseling and testing to include BRCA1 and BRCA2 at minimum,” she remarked. “Those endorsements continue to

Full access

NCCN News

dedicated to empowering patients. By expanding the availability of this information, it will increase awareness in genetic testing, share tools for a more proactive approach to health, and provide greater access to genetic counseling and testing, ultimately

Full access

NCCN News

.2013 to Version 1.2015 to reflect the most recent updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Ovarian Cancer. This update includes many important changes and additions, such as addressing genetic counseling as part of

Full access

A Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care Appointments

Shu Fen Wong, Richard Norman, Trisha Lynette Dunning, David Michael Ashley, Mustafa Khasraw, Theresa Margaret Hayes, Ian Collins, and Paula Kate Lorgelly

-stage breast cancer changed their preferences after a medical consultation. Choice-based techniques such as discrete choice experiments (DCE) 4 have been successfully used to evaluate genetic counseling for cancer, 5 screening programs, 6 and cancer